Single-fraction SBRT for Early Stage NSCLC-A Viable Option in “These Uncertain Times”?

Joseph K. Salama; Meredith E. Giuliani; Clifford G. Robinson; Megan E. Daly

doi:10.1016/j.ijrobp.2020.08.031

Single-fraction SBRT for Early Stage NSCLC-A Viable Option in “These Uncertain Times”?

Joseph K. Salama, Meredith E. Giuliani, Clifford G. Robinson, Megan E. Daly

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	1-4
Number of pages	4
Journal	International Journal of Radiation Oncology Biology Physics
Volume	109
Issue number	1
DOIs	https://doi.org/10.1016/j.ijrobp.2020.08.031
State	Published - Jan 1 2021

Access to Document

10.1016/j.ijrobp.2020.08.031

Cite this

@article{e5057c4858ab48788f329d2d854a1146,

title = "Single-fraction SBRT for Early Stage NSCLC-A Viable Option in “These Uncertain Times”?",

author = "Salama, {Joseph K.} and Giuliani, {Meredith E.} and Robinson, {Clifford G.} and Daly, {Megan E.}",

note = "Funding Information: Disclosures: J.K.S. receives funding from AbbVie, Merck, Array, and BMS. M.G. receives funding from Elekta, AstraZeneca, and BMS. C.R. receives research funding from Elekta, Varian, and Merck; is a consultant for AstraZeneca, EMD Serono, and Radialogica; and holds equity in Radialogica. M.E.C. receives research funding from EMD Serono and Genentech and is a consultant for Boston Scientific and Triptych Health Partners. ",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/j.ijrobp.2020.08.031",

language = "English",

volume = "109",

pages = "1--4",

journal = "International Journal of Radiation Oncology Biology Physics",